Cooper Companies

COO

Market cap $15.5B

The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cooper's Lack of Strategic Focus, Misaligned Incentives, and Inadequate Board Oversight Have Led to Meaningful Underperformance

Jana announced a top portfolio position in Cooper and plans to push for strategic alternatives, including a potential combination for its contact lens unit.

SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results on Thursday, December 4, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.

Shares of Cooper Companies (COO) rallied on Monday's session as an activist investor eyes a turnaround. Reports say Jana Partners is pushing for the company to merge with Bausch + Lomb (BLCO) among other strategic alternatives as the stock remains 30% lower year-over-year.

The hedge fund will push Cooper to improve how it allocates capital in order to boost returns, the WSJ said.

Bausch + Lomb is seen as a potential buyer for the contact-lens unit and the CEO said he would be interested.

Cooper Companies may strongly outperform the S&P 500 going forward, especially in a recessionary environment, rebounding from 2025's sell-off. COO trades at decade-low enterprise valuations, with renewed insider buying, positive trading momentum, and a history of resilience during economic downturns. The company leads the global contact lens market, maintains a solid balance sheet, and just expanded its share repurchase program by $1 billion.

The Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock?